<!-- received="Fri Jun  4 11:59:15 1999 MDT" -->
<!-- sent="Fri, 4 Jun 1999 10:58:34 -0700 " -->
<!-- name="Al Villalobos" -->
<!-- email="ALV@qm.com" -->
<!-- subject="RE: beta carotene increases mortality" -->
<!-- id="41E42D04E878D211A99F00A0C9A8AC620EDBE0@QMEXCHANGE" -->
<!-- inreplyto="" -->
<!-- version=1.10, linesinbody=117 -->
<html><head><title>extropians: RE: beta carotene increases mortality</title>
<meta name=author content="Al Villalobos">
<link rel=author rev=made href="mailto:ALV@qm.com" title ="Al Villalobos">
</head><body>
<h1>RE: beta carotene increases mortality</h1>
Al Villalobos (<i>ALV@qm.com</i>)<br>
<i>Fri, 4 Jun 1999 10:58:34 -0700 </i>
<p>
<ul>
<li> <b>Messages sorted by:</b> <a href="date.html#2784">[ date ]</a><a href="index.html#2784">[ thread ]</a><a href="subject.html#2784">[ subject ]</a><a href="author.html#2784">[ author ]</a>
<!-- next="start" -->
<li><a href="2785.html">[ Next ]</a><b>In reply to:</b> <a href="2783.html">Elizabeth Childs</a>
<!-- nextthread="start" -->
<b>Next in thread:</b> <a href="2786.html">Diego A. Mayer-Cantu</a>
</ul>
<!-- body="start" -->

<p>
<a name="2786qlink1">Just the opposite, they die sooner than expected.</a>


<p>
<i>&gt; -----Original Message-----</i><br>
<i>&gt; From:	Elizabeth Childs [SMTP:echilds@linex.com]</i><br>
<i>&gt; Sent:	Friday, June 04, 1999 10:00 AM</i><br>
<i>&gt; To:	extropians@extropy.com</i><br>
<a href="2783.html#2784qlink1">&gt; Subject:	Re: beta carotene increases mortality</a><br>
<i>&gt; </i><br>
<i>&gt; So when they say "increases mortality" they mean that the experimental</i><br>
<i>&gt; subjects live longer?</i><br>
<i>&gt; </i><br>
<i>&gt; Doug Skrecky wrote:</i><br>
<i>&gt; &gt; </i><br>
<i>&gt; &gt; Citations: 1-2</i><br>
<i>&gt; &gt; &lt;1&gt;</i><br>
<i>&gt; &gt; Authors</i><br>
<i>&gt; &gt;   Omenn GS.</i><br>
<i>&gt; &gt; Institution</i><br>
<i>&gt; &gt;   School of Public Health &amp; Community Medicine, University of</i><br>
<i>&gt; Washington,</i><br>
<i>&gt; &gt;   Seattle 98195-7230, USA. gomenn@umich.edu</i><br>
<i>&gt; &gt; Title</i><br>
<i>&gt; &gt;   Chemoprevention of lung cancer: the rise and demise of</i><br>
<i>&gt; &gt;   beta-carotene. [Review] [124 refs]</i><br>
<i>&gt; &gt; Source</i><br>
<i>&gt; &gt;   Annual Review of Public Health.  19:73-99, 1998.</i><br>
<i>&gt; &gt; Abstract</i><br>
<i>&gt; &gt;   Beta-carotene and retinoids were the most</i><br>
<i>&gt; &gt;   promising agents against common cancers when the National Cancer</i><br>
<i>&gt; Institute</i><br>
<i>&gt; &gt;   mounted a substantial program of population-based trials in the early</i><br>
<i>&gt; 1980s.</i><br>
<i>&gt; &gt;   Both major lung cancer chemoprevention trials not only showed no</i><br>
<i>&gt; benefit, but</i><br>
<i>&gt; &gt;   had significant increases in lung cancer incidence and in</i><br>
<i>&gt; cardiovascular and</i><br>
<i>&gt; &gt;   total mortality. A new generation of laboratory research has</i><br>
<i>&gt; &gt;   been stimulated. Rational public health recommendations at this time</i><br>
<i>&gt; include:</i><br>
<i>&gt; &gt;   1. Five-A-Day servings of fruits and vegetables, a doubling of current</i><br>
<i>&gt; mean</i><br>
<i>&gt; &gt;   intake; 2. systematic investigation of the covariates of extremes of</i><br>
<i>&gt; fruit</i><br>
<i>&gt; &gt;   and vegetable intake; 3. discouragement of</i><br>
<i>&gt; &gt;   beta-carotene supplement use, due to</i><br>
<i>&gt; &gt;   adverse effects in smokers and no evidence of benefit in non-smokers;</i><br>
<i>&gt; 4.</i><br>
<i>&gt; &gt;   multilevel research to develop and evaluate candidate chemoprevention</i><br>
<i>&gt; agents</i><br>
<i>&gt; &gt;   to prevent lung and other common cancers; and 5. continued priority</i><br>
<i>&gt; for</i><br>
<i>&gt; &gt;   smoking prevention, smoking cessation, and avoidance of known</i><br>
<i>&gt; carcinogens in</i><br>
<i>&gt; &gt;   the environment. [References: 124]</i><br>
<i>&gt; &gt; </i><br>
<i>&gt; &gt; &lt;2&gt;</i><br>
<i>&gt; &gt; Authors</i><br>
<i>&gt; &gt;   Heinonen OP.  Albanes D.  Virtamo J.  Taylor PR.  Huttunen JK.</i><br>
<i>&gt; Hartman AM.</i><br>
<i>&gt; &gt;   Haapakoski J.  Malila N.  Rautalahti M.  Ripatti S.  Maenpaa H.</i><br>
<i>&gt; Teerenhovi</i><br>
<i>&gt; &gt;   L.  Koss L.  Virolainen M.  Edwards BK.</i><br>
<i>&gt; &gt; Institution</i><br>
<i>&gt; &gt;   Department of Public Health, University of Helsinki, Finland.</i><br>
<i>&gt; &gt; Title</i><br>
<i>&gt; &gt;   Prostate cancer and supplementation with alpha-tocopherol and</i><br>
<i>&gt; &gt;   beta-carotene: incidence and</i><br>
<i>&gt; &gt;   mortality in a controlled trial [see comments].</i><br>
<i>&gt; &gt; Comments</i><br>
<i>&gt; &gt;   Comment in: J Natl Cancer Inst 1998 Mar 18;90(6):414-5, Comment in: J</i><br>
<i>&gt; Natl</i><br>
<i>&gt; &gt;   Cancer Inst 1998 Mar 18;90(6):416-7</i><br>
<i>&gt; &gt; Source</i><br>
<i>&gt; &gt;   Journal of the National Cancer Institute.  90(6):440-6, 1998 Mar 18.</i><br>
<i>&gt; &gt; Abstract</i><br>
<i>&gt; &gt;   BACKGROUND: Epidemiologic studies have suggested that vitamin E and</i><br>
<i>&gt; &gt;   beta-carotene may each influence the</i><br>
<i>&gt; &gt;   development of prostate cancer. In the Alpha-Tocopherol,</i><br>
<i>&gt; &gt;   Beta-Carotene Cancer Prevention Study, a</i><br>
<i>&gt; &gt;   controlled trial, we studied the effect of alpha-tocopherol (a form of</i><br>
<i>&gt; &gt;   vitamin E) and beta-carotene</i><br>
<i>&gt; &gt;   supplementation, separately or together, on prostate cancer in male</i><br>
<i>&gt; smokers.</i><br>
<i>&gt; &gt;   METHODS: A total of 29133 male smokers aged 50-69 years from</i><br>
<i>&gt; southwestern</i><br>
<i>&gt; &gt;   Finland were randomly assigned to receive alpha-tocopherol (50 mg),</i><br>
<i>&gt; &gt;   beta-carotene (20 mg), both agents, or</i><br>
<i>&gt; &gt;   placebo daily for 5-8 years (median, 6.1 years). The supplementation</i><br>
<i>&gt; effects</i><br>
<i>&gt; &gt;   were estimated by a proportional hazards model, and two-sided P values</i><br>
<i>&gt; were</i><br>
<i>&gt; &gt;   calculated. RESULTS: We found 246 new cases of and 62 deaths from</i><br>
<i>&gt; prostate</i><br>
<i>&gt; &gt;   cancer during the follow-up period. A 32% decrease (95% confidence</i><br>
<i>&gt; interval</i><br>
<i>&gt; &gt;   [CI] = -47% to -12%) in the incidence of prostate cancer was observed</i><br>
<i>&gt; among</i><br>
<i>&gt; &gt;   the subjects receiving alpha-tocopherol (n = 14564) compared with</i><br>
<i>&gt; those not</i><br>
<i>&gt; &gt;   receiving it (n = 14569). The reduction was evident in clinical</i><br>
<i>&gt; prostate</i><br>
<i>&gt; &gt;   cancer but not in latent cancer. Mortality from prostate</i><br>
<i>&gt; &gt;   cancer was 41% lower (95% CI = -65% to -1%) among men receiving</i><br>
<i>&gt; &gt;   alpha-tocopherol. Among subjects receiving</i><br>
<i>&gt; &gt;   beta-carotene (n = 14560), prostate cancer</i><br>
<i>&gt; &gt;   incidence was 23% higher (95% CI = -4%-59%) and mortality</i><br>
<i>&gt; &gt;   was 15% higher (95% CI = -30%-89%) compared with those not receiving</i><br>
<i>&gt; it (n =</i><br>
<i>&gt; &gt;   14573). Neither agent had any effect on the time interval between</i><br>
<i>&gt; diagnosis</i><br>
<i>&gt; &gt;   and death. CONCLUSIONS: Long-term supplementation with</i><br>
<i>&gt; alpha-tocopherol</i><br>
<i>&gt; &gt;   substantially reduced prostate cancer incidence and</i><br>
<i>&gt; &gt;   mortality in male smokers. Other controlled trials are</i><br>
<i>&gt; &gt;   required to confirm the findings.</i><br>
<!-- body="end" -->
<p>
<ul>
<!-- next="start" -->
<li><a href="2785.html">[ Next ]</a>
<b>In reply to:</b> <a href="2783.html">Elizabeth Childs</a>
<!-- nextthread="start" -->
<b>Next in thread:</b> <a href="2786.html">Diego A. Mayer-Cantu</a>
</ul>
</body></html>
